← Leaderboards
Andrea L Kasinski
Yale University
$6,446,205
Attributed
$6,446,205
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $772.2K · FY2010–25$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,446,205 · 5
By mechanism
R01$5,565,092 · 2
R00$733,920 · 1
K99$99,587 · 1
F32$47,606 · 1
Top collaborators
No co-investigators on record.
Most similar at Yale University
Same institution · by research overlap
- Priti Kumar$9,682,784
- Jordan S Pober$30,894,969
- Harriet M Kluger$18,066,555
- David Stitelman$632,095
- Oliver Hobert$22,660,899
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMalignant NeoplasmsTumorMicrornasKineticsIn VivoLeadMalignant Neoplasm Of LungCancer TherapyTherapeutic MirnaToxic EffectPublic HealthSmall RnaMediatingMissionPathway InteractionsPreventOverexpressionAntineoplastic AgentsUnited States National Institutes Of HealthGenerationsLigandsMouse ModelBase
Grant awards (21)
Enhancing miRNA Therapeutics through Vehicle Free Delivery$386,127
R01 · FY2025 · CA · contact PI
Ligand-mediated, vehicle-free delivery of small RNAs$386,024
R01 · FY2025 · CA · contact PI
Enhancing miRNA Therapeutics through Vehicle Free Delivery$386,127
R01 · FY2024 · CA · contact PI
Ligand-mediated, vehicle-free delivery of small RNAs$366,844
R01 · FY2024 · CA · contact PI
Ligand-mediated, vehicle-free delivery of small RNAs$386,276
R01 · FY2023 · CA · contact PI
Ligand-mediated, vehicle-free delivery of small RNAs$362,589
R01 · FY2022 · CA · contact PI
Ligand-mediated, vehicle-free delivery of small RNAs$406,459
R01 · FY2021 · CA · contact PI
Enhancing miRNA Therapeutics through Combinatorial Targeting and Vehicle Free Delivery$354,563
R01 · FY2021 · CA · contact PI
Ligand-mediated, vehicle-free delivery of small RNAs$406,567
R01 · FY2020 · CA · contact PI
Enhancing miRNA Therapeutics through Combinatorial Targeting and Vehicle Free Delivery$354,563
R01 · FY2020 · CA · contact PI
Ligand-mediated, vehicle-free delivery of small RNAs$338,811
R01 · FY2019 · CA · contact PI
Enhancing miRNA Therapeutics through Combinatorial Targeting and Vehicle Free Delivery$338,785
R01 · FY2019 · CA · contact PI
Ligand-mediated, vehicle-free delivery of small RNAs$43,760
R01 · FY2019 · CA · contact PI
Enhancing miRNA Therapeutics through Combinatorial Targeting and Vehicle Free Delivery$349,332
R01 · FY2018 · CA · contact PI
Ligand-mediated, vehicle-free delivery of small RNAs$348,866
R01 · FY2018 · CA · contact PI
Enhancing miRNA Therapeutics through Combinatorial Targeting and Vehicle Free Delivery$349,399
R01 · FY2017 · CA · contact PI
Identification and Therapeutic Application of miRNA-Drivers in Lung Cancer$244,646
R00 · FY2016 · CA · contact PI
Identification and Therapeutic Application of miRNA-Drivers in Lung Cancer$247,745
R00 · FY2015 · CA · contact PI
Identification and Therapeutic Application of miRNA-Drivers in Lung Cancer$241,529
R00 · FY2014 · CA · contact PI
Identification and therapeutic application of miRNA-drivers in lung cancer$99,587
K99 · FY2013 · CA · contact PI
Therapeutic use of let-7 and miR-34 microRNAs for the prevention and treatment of$47,606
F32 · FY2010 · CA · contact PI